The Wire · All news

Ozempic / GLP-1 Lawsuits

FDA Issues Class I Recall for Omnipod 5 Insulin Pods Over Leak Risk

Published Updated

By People's Justice

What happened

The FDA posted a Class I recall for specific Omnipod 5 pod models manufactured by Insulet Corporation. According to the recall notice, a manufacturing defect can damage the external soft cannula, causing insulin to leak around the pod rather than being delivered to the user. The FDA noted that failure to deliver insulin properly could lead to serious health consequences.

Event date:

Source: api.fda.gov

Related news

  1. Ozempic / GLP-1 Lawsuits

  2. Ozempic / GLP-1 Lawsuits

  3. Ozempic / GLP-1 Lawsuits

    Search Interest in Ozempic Recalls and Side Effects Surges

    Google Trends data recorded sharp week-over-week increases in searches for terms including "ozempic news" (up 750%), "ozempic news today" (up 950%), "ozempic recall 2025" (up 130%), and "side effects of semaglutide" (up 350%), along with breakout interest in "what is ozempic 2.0." This reflects rising public search activity, not a confirmed regulatory, legal, or court development.

    Source: trends.google.com